Drawing on 35 years of experience in the development and production of high-temperature ceramic fibre, RATH is always looking ...

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the progress of the U.S. commercial launch of Ryoncil ® ...

Patients who are unresponsive to 4–8 weeks' treatment with PPIs twice daily might have so-called refractory GERD. The first investigation these patients should undergo is upper endoscopy to ...

This variety of monolithic refractories has been specially formulated for aluminum contact. Now, the Fast Dry technology can be seamlessly integrated into the ALKON ® range. Previously, fast-drying ...

The humanised trispecific antibody is undergoing Phase I clinical trials in the US and China in subjects with relapsed or refractory multiple myeloma (MM). Simcere Zaiming will gain an upfront payment ...

Autologous SUPLEXA is under clinical development by Alloplex Biotherapeutics and currently in Phase I for Refractory Chronic Lymphocytic Leukemia (CLL). According to GlobalData, Phase I drugs for ...

Online submission of application form 02 January to 01 February 2025 (up to 11:50 P.M.) Last date for successful fee transaction 02 February 2025 (up to 11:50 P.M.) Correction in application ...

Fapon Biopharma plans to submit an Investigational New Drug (IND) application for FP008 to the U.S. Food and ... anti-PD-1/IL-10M fusion protein designed to address anti-PD1 refractory/resistance ...